Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing needs than it was during the COVID-19 pandemic.
Becton Dickinson to Spin Off Biosciences and Diagnostics Business as Q1 Revenues Grow 10 Percent
Premium
The separation is planned to be completed by the end of 2026 with the rest of the company transforming into a pure play medical technology firm.
The company said that its molecular diagnostics revenues rose 7 percent on the strength of its women's health assays and Biotheranostics business.
Brown University Health Pneumonia MDx Development Offers Hint of Digital PCR's Potential as IVD Tool
Premium
The pneumonia test will detect pathogen RNA in blood samples using Qiagen's newly launched clinical system.
Oxford Team Debuts Multi-Modal MCED Approach Built on Exact Sciences Methylation Sequencing Tech
Premium
The group's TriOx assay sensitively detected cancers, including at early stages, using combined sequencing of methylation and gene alterations.
The digital pathology software developer is raising funding that would help it to increase its head count and support its Aiosyn Mitosis Breast application.
The firm is developing a protein-based lung cancer screening test that also utilizes machine learning.